26 CFR § 51.6302-1 - Method of paying the branded prescription drug fee.
---
identifier: "/us/cfr/t26/s51.6302-1"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "26 CFR § 51.6302-1 - Method of paying the branded prescription drug fee."
title_number: 26
title_name: "Internal Revenue"
section_number: "51.6302-1"
section_name: "Method of paying the branded prescription drug fee."
chapter_name: "INTERNAL REVENUE SERVICE, DEPARTMENT OF THE TREASURY"
subchapter_number: "D"
subchapter_name: "MISCELLANEOUS EXCISE TAXES"
part_number: "51"
part_name: "BRANDED PRESCRIPTION DRUG FEE"
positive_law: false
currency: "2026-03-24"
last_updated: "2026-03-24"
format_version: "1.1.0"
generator: "[email protected]"
authority: "26 U.S.C. 7805; sec. 9008, Pub. L. 111-148, 124 Stat. 119."
regulatory_source: "T.D. 9544, 76 FR 51249, Aug. 18, 2011, unless otherwise noted."
cfr_part: "51"
---
# 51.6302-1 Method of paying the branded prescription drug fee.
(a) *Fee to be paid by electronic funds transfer.* Under the authority of section 6302(a), the fee imposed on branded prescription drug sales by section 9008 and § 51.5 must be paid by electronic funds transfer as defined in § 31.6302-1(h)(4)(i) of this title, as if the fee were a depository tax. For the time for paying the fee, see § 51.8.
(b) *Effective/applicability date.* This section applies on and after July 28, 2014.
[T.D. 9684, 79 FR 43645, July 28, 2014]